AmCyte Company

AmCyte develops encapsulated proliferated human islets for transplantation into patients with diabetes. The company specializes in adult stem cell research to treat diabetes with islet replacement therapy.
Technology: Stem Cell
Industry: Regenerative medicine
Headquarters: United States
Founded Date: 1991-01-01
Funding Status: M&A

Visit Website
Register and Claim Ownership